These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34084)

  • 21. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)].
    Birk W; Schmidt HA; Petrides P
    Arzneimittelforschung; 1978; 28(2):330-7. PubMed ID: 416832
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metipranolol 0.1%: effect of a single dose on the nycthemeral pressure curve in an eye with chronic primary open-angle glaucoma].
    Demailly P; Lecherpie F
    J Fr Ophtalmol; 1987; 10(6-7):447-9. PubMed ID: 2891739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].
    Heuer LJ; Kaufmann HH
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):52-8. PubMed ID: 3924553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect on carbohydrate metabolism of a new saluretic, etozolin].
    Haslbeck M; Renner R; Kemmler W; Schneider B; Mehnert H
    Fortschr Med; 1979 Oct; 97(40):1825-30. PubMed ID: 396216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of nuredal on carbohydrate metabolism in diabetes mellitus].
    Wójcikiewicz O; Szopińska-Ciba L
    Pol Tyg Lek; 1970 Jan; 25(3):97-9. PubMed ID: 5414802
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical studies of the interaction between tolmetin and glibenclamide.
    Chlud K; Kaik B
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):409-10. PubMed ID: 410740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of glibenclamide, gliquidone, glisoxepide and placebo in maturity onset diabetics of differing degrees of severity (author's transl)].
    Irsigler K; Ogris E; Steinhardt T; Brändle J; Regal H; Zdolsek I
    Wien Klin Wochenschr; 1979 Aug; 91(16):541-50. PubMed ID: 115159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 32. [Carbohydrate metabolism in patients with chronic pyoderma and its dynamics during therapy using sugar-decreasing preparations].
    Bukharovich AM
    Vestn Dermatol Venerol; 1989; (6):14-7. PubMed ID: 2588784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
    Giangrandi E; Scaroina F; Tommasini-Degna C
    Minerva Med; 1975 Mar; 66(19):940-5. PubMed ID: 804684
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics].
    Janka HU; Ziegler AG; Larrat V; Mehnert H
    Arzneimittelforschung; 1989 May; 39(5):615-7. PubMed ID: 2569309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.
    Vray M; Attali JR
    Diabete Metab; 1995 Dec; 21(6):433-9. PubMed ID: 8593925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR; Wragg KG; Shetty KT; Biggs PI; Davies CD
    Horm Metab Res; 1979 Jun; 11(6):411-2. PubMed ID: 112018
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetics of the beta-receptor blocker metipranolol in patients with liver cirrhosis (author's transl)].
    Seyfried C; Ledermann H; Rennekamp H; L'age M; Abshagen U
    Dtsch Med Wochenschr; 1982 Jan; 107(1):21-6. PubMed ID: 6120063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations into the action of high doses of saccharin on the metabolism in diabetics (author's transl)].
    Pröls H; Haslbeck M; Mehnert H
    Dtsch Med Wochenschr; 1973 Oct; 98(41):1901-4. PubMed ID: 4758618
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of metipranolol, practolol, and pindolol on the taenia coli of the guinea-pig (author's transl)].
    Bauer V
    Bratisl Lek Listy; 1981 Oct; 76(4):481-7. PubMed ID: 6117355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.